The U.S. Department of Justice (DOJ) filed a complaint against a pharmaceutical company, claiming it had manipulated reimbursements for its eye care drug, thereby defrauding the country’s federal health insurance program and taxpayers of hundreds of millions of dollars.
Related Posts
Fleeing Ukrainians Face Interrogation in Transnistria
Ukrainian men fleeing conscription are being detained and questioned in Transnistria by security forces linked to Russia,… Read More
Trump Threatens 50% Tariffs on Brazil over Bolsonaro Trial
U.S. President targets Brazil’s imports amid legal battle against Jair Bolsonaro, sparking sharp backlash from President… Read More
Ousted Bangladesh PM Sheikh Hasina Indicted Over Protester Deaths
A Bangladeshi special court on Thursday formally indicted deposed Prime Minister Sheikh Hasina on charges of crimes against… Read More